Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by the Proteasome Inhibitor Bortezomib

Publisher： Karger

E-ISSN： 1421-9662|115|1-2|78-90

ISSN： 0001-5792

Source： Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 78-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 2, 2015-04 ,pp. : 248-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms

By      

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 513-532

Spandidos Publications

Access to resources Recommend Favorite

The Oral Histone Deacetylase Inhibitor LBH589 Is a Potential and Promising Therapeutic Agent in Multiple Myeloma after at Least Two Lines of Chemotherapy Including Bortezomib or Lenalidomide

By  

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs

By          

International Journal of Molecular Medicine, Vol. 29, Iss. 1, 2012-01 ,pp. : 102-106

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase inhibitor for NUT midline carcinoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 715-717

John Wiley & Sons Inc

Access to resources Recommend Favorite